2016
DOI: 10.1001/jama.2016.11237
|View full text |Cite
|
Sign up to set email alerts
|

The High Cost of Prescription Drugs in the United States

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
420
3
6

Year Published

2016
2016
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 484 publications
(437 citation statements)
references
References 94 publications
0
420
3
6
Order By: Relevance
“…On average, per capita spending on prescription drugs in the United States is $858, compared with an average of $400 in 19 other industrialized countries. 6 Patients' opinion of the efficacy of drug therapy in CVD prevention is often inflated multifold. 7,8 It has been estimated that high-risk patients have a < 5% chance of benefiting from cardioprotective drugs within the next 5 years.…”
Section: Introductionmentioning
confidence: 99%
“…On average, per capita spending on prescription drugs in the United States is $858, compared with an average of $400 in 19 other industrialized countries. 6 Patients' opinion of the efficacy of drug therapy in CVD prevention is often inflated multifold. 7,8 It has been estimated that high-risk patients have a < 5% chance of benefiting from cardioprotective drugs within the next 5 years.…”
Section: Introductionmentioning
confidence: 99%
“…Academic detailing through evidence-based information by specially trained noncommercial outreach educators to physician offices has been shown to be effective in more than 60 randomized controlled trials and could be targeted to specific locations or practice characteristics from future studies such as this. 9 Furthermore, with the emergence of health care systems, there are opportunities for information feedback where physicians could be rewarded for prescribing drugs optimally. …”
Section: Discussionmentioning
confidence: 99%
“…However, while the pharmaceutical and biotech industries may assume considerable risk, they have also consistently been among the most profitable sectors of the U.S. economy [10]. Moreover, data show that large pharmaceutical corporations invest just 10 to 20 percent of their revenue in research and development [11]. Additionally, an analysis of corporate filings indicates that between 2005 and 2010 drug companies spent 19 times more on promotion and marketing of new drugs than on research [12].…”
Section: Factors Accounting For the High Prices And Pharmaceutical Comentioning
confidence: 99%